Tirzepatide is a novel dual?receptor agonist synthetic peptide, which can activate both GLP?1 receptor and GIP receptor. Structural lipid modification extends its biological half?life, making it a key research material for metabolic related pre?clinical studies.

It participates in regulating insulin release, blood glucose balance, food intake and energy metabolism. It is commonly used in pre?clinical research of obesity, diabetes, glucose tolerance and metabolic disorder animal models, suitable for cell experiments and in?vivo animal research.

Our Tirzepatide adopts mature solid?phase peptide synthesis process. Each batch is subjected to HPLC and mass spectrometry testing to confirm product purity and molecular identity. COA is available upon request. Lyophilized powder form maintains excellent stability during transportation and long?term preservation. Various packaging options are supported, from small lab sample vials to bulk kilogram?level orders.

Warning: This product is exclusively for scientific laboratory research. It shall not be used for human consumption, injection, clinical diagnosis or therapy.

Ready for Gedai chemical website upload. Tell me next peptide name.